- Home
- NBTX vs FRAF Comparison
NBTX vs FRAF Comparison
Compare NBTX & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- FRAF
- Stock Information
- Founded
- NBTX 2003
- FRAF 1906
- Country
- NBTX France
- FRAF United States
- Employees
- NBTX N/A
- FRAF N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- FRAF Major Banks
- Sector
- NBTX Health Care
- FRAF Finance
- Exchange
- NBTX Nasdaq
- FRAF Nasdaq
- Market Cap
- NBTX 178.7M
- FRAF 165.3M
- IPO Year
- NBTX 2020
- FRAF N/A
- Fundamental
- Price
- NBTX $3.61
- FRAF $35.40
- Analyst Decision
- NBTX Strong Buy
- FRAF
- Analyst Count
- NBTX 1
- FRAF 0
- Target Price
- NBTX $12.00
- FRAF N/A
- AVG Volume (30 Days)
- NBTX 13.1K
- FRAF 17.0K
- Earning Date
- NBTX 04-23-2025
- FRAF 04-22-2025
- Dividend Yield
- NBTX N/A
- FRAF 3.59%
- EPS Growth
- NBTX N/A
- FRAF N/A
- EPS
- NBTX N/A
- FRAF 2.51
- Revenue
- NBTX $45,220,186.00
- FRAF $69,210,000.00
- Revenue This Year
- NBTX N/A
- FRAF N/A
- Revenue Next Year
- NBTX N/A
- FRAF N/A
- P/E Ratio
- NBTX N/A
- FRAF $14.13
- Revenue Growth
- NBTX 526.17
- FRAF 5.24
- 52 Week Low
- NBTX $2.76
- FRAF $25.11
- 52 Week High
- NBTX $7.51
- FRAF $38.41
- Technical
- Relative Strength Index (RSI)
- NBTX 52.08
- FRAF 41.01
- Support Level
- NBTX $3.32
- FRAF $34.94
- Resistance Level
- NBTX $3.77
- FRAF $36.83
- Average True Range (ATR)
- NBTX 0.21
- FRAF 0.75
- MACD
- NBTX 0.01
- FRAF -0.17
- Stochastic Oscillator
- NBTX 60.55
- FRAF 19.09
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.